second-line treatment: tki combination therapy
Published 4 years ago • 78 plays • Length 6:23Download video MP4
Download video MP3
Similar videos
-
2:32
second-line therapy decision factors
-
3:42
second-line combination therapy in mrcc
-
2:07
dose-reductions in second-line tki treatment of hcc
-
3:20
choosing a tki in second-line metastatic hcc
-
4:14
second-line treatment options for advanced rcc
-
3:12
egfr-tki therapy in advanced nsclc
-
20:24
targeted treatment with egfr tkis: front line options
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents
-
3:06
selecting second-line therapy for alk nsclc
-
3:04
mrcc: factors for choosing second-line therapy
-
4:23
second-line options for poor-risk advanced rcc
-
5:01
approaching second-line therapy for advanced hcc
-
6:23
frontline chemo and tki combination in egfr nsclc
-
3:33
poor-risk advanced rcc: tki therapy & outlook
-
5:56
tki therapy: impact of age and adverse events
-
2:26
additional egfr-tki therapy research in nsclc
-
2:26
itp: second-line therapy
-
4:44
second-line therapy and beyond for itp
-
19:11
improving outcomes in egfrm nsclc with tki combination treatment | dr. natasha leighl | crsf 2023